CRISPR Therapeutics AG
Nasdaq CRSP · Zug, Switzerland
Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Renal & urogenital · Respiratory · Women's health
CRISPR Therapeutics AG is a clinical trial sponsor based in Zug, Switzerland, listed as Nasdaq CRSP. It has 8 active clinical trials with 777 planned participants, across 15 therapeutic areas. Since 2021 it has completed 3 trials and stopped 5 early.
Trial track record · since 2021
Financials · Nasdaq CRSP
Fundraising
Pipeline · 8 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about CRISPR Therapeutics AG
CRISPR Therapeutics AG is lead sponsor of 8 active clinical trials on ClinicalTrials.gov, with 777 planned participants, in Cardiovascular, Dermatology, Genetic & rare, GI & liver and other areas. Since 2021 it has completed 3 trials and stopped 5 early.
CRISPR Therapeutics AG is based in Zug, Switzerland and is listed as Nasdaq CRSP. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with CRISPR Therapeutics AG; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-30.
Approve Suite is not affiliated with CRISPR Therapeutics AG.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.